Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
International Journal of Molecular Sciences
|
August 14, 2019
The Mode-of-Action of Targeted Alpha Therapy Radium-223 as an Enabler for Novel Combinations to Treat Patients with Bone Metastasis
Mari I Suominen, Timothy Wilson, Sanna-Maria Käkönen, et al.
Calcified Tissue International
|
December 18, 2007
Secreted tartrate-resistant acid phosphatase 5b is a Marker of osteoclast number in human osteoclast cultures and the rat ovariectomy model
Jukka P Rissanen, Mari I Suominen, Zhiqi Peng, et al.
Calcified Tissue International
|
January 26, 2008
Short-term changes in serum PINP predict long-term changes in trabecular bone in the rat ovariectomy model
Jukka P Rissanen, Mari I Suominen, Zhiqi Peng, et al.
Cancers
|
August 26, 2023
Zoledronic Acid Prevents Bone Resorption Caused by the Combination of Radium-223, Abiraterone Acetate, and Prednisone in an Intratibial Prostate Cancer Mouse Model
Mari I Suominen, Matias Knuuttila, Birgitta Sjöholm, et al.
Journal of Immunology Research
|
June 19, 2019
Human Immune System Increases Breast Cancer-Induced Osteoblastic Bone Growth in a Humanized Mouse Model without Affecting Normal Bone
Tiina E Kähkönen, Mari I Suominen, Jenni H E Mäki-Jouppila, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 30, 2012
Improved statistical modeling of tumor growth and treatment effect in preclinical animal studies with highly heterogeneous responses in vivo
Teemu D Laajala, Jukka Corander, Niina M Saarinen, et al.
International Journal of Molecular Sciences
|
January 8, 2025
Darolutamide in Combination with Radium-223 Exhibits Synergistic Antitumor Efficacy in LNCaP Prostate Cancer Models
Urs B Hagemann, Christoph A Schatz, Mari I Suominen, et al.
International Journal of Molecular Sciences
|
February 11, 2023
Enhanced Antitumor Efficacy of Radium-223 and Enzalutamide in the Intratibial LNCaP Prostate Cancer Model
Mari I Suominen, Matias Knuuttila, Christoph A Schatz, et al.
Journal of the National Cancer Institute
|
May 18, 2013
Survival benefit with radium-223 dichloride in a mouse model of breast cancer bone metastasis
Mari I Suominen, Jukka P Rissanen, Rami Käkönen, et al.
International Journal of Molecular Sciences
|
June 2, 2021
Additive Benefits of Radium-223 Dichloride and Bortezomib Combination in a Systemic Multiple Myeloma Mouse Model
Mari I Suominen, Jenni Mäki-Jouppila, Anna Huhtinen, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
International Journal of Molecular Sciences
|
August 14, 2019
The Mode-of-Action of Targeted Alpha Therapy Radium-223 as an Enabler for Novel Combinations to Treat Patients with Bone Metastasis
Mari I Suominen, Timothy Wilson, Sanna-Maria Käkönen, et al.
Calcified Tissue International
|
December 18, 2007
Secreted tartrate-resistant acid phosphatase 5b is a Marker of osteoclast number in human osteoclast cultures and the rat ovariectomy model
Jukka P Rissanen, Mari I Suominen, Zhiqi Peng, et al.
Calcified Tissue International
|
January 26, 2008
Short-term changes in serum PINP predict long-term changes in trabecular bone in the rat ovariectomy model
Jukka P Rissanen, Mari I Suominen, Zhiqi Peng, et al.
Cancers
|
August 26, 2023
Zoledronic Acid Prevents Bone Resorption Caused by the Combination of Radium-223, Abiraterone Acetate, and Prednisone in an Intratibial Prostate Cancer Mouse Model
Mari I Suominen, Matias Knuuttila, Birgitta Sjöholm, et al.
Journal of Immunology Research
|
June 19, 2019
Human Immune System Increases Breast Cancer-Induced Osteoblastic Bone Growth in a Humanized Mouse Model without Affecting Normal Bone
Tiina E Kähkönen, Mari I Suominen, Jenni H E Mäki-Jouppila, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 30, 2012
Improved statistical modeling of tumor growth and treatment effect in preclinical animal studies with highly heterogeneous responses in vivo
Teemu D Laajala, Jukka Corander, Niina M Saarinen, et al.
International Journal of Molecular Sciences
|
January 8, 2025
Darolutamide in Combination with Radium-223 Exhibits Synergistic Antitumor Efficacy in LNCaP Prostate Cancer Models
Urs B Hagemann, Christoph A Schatz, Mari I Suominen, et al.
International Journal of Molecular Sciences
|
February 11, 2023
Enhanced Antitumor Efficacy of Radium-223 and Enzalutamide in the Intratibial LNCaP Prostate Cancer Model
Mari I Suominen, Matias Knuuttila, Christoph A Schatz, et al.
Journal of the National Cancer Institute
|
May 18, 2013
Survival benefit with radium-223 dichloride in a mouse model of breast cancer bone metastasis
Mari I Suominen, Jukka P Rissanen, Rami Käkönen, et al.
International Journal of Molecular Sciences
|
June 2, 2021
Additive Benefits of Radium-223 Dichloride and Bortezomib Combination in a Systemic Multiple Myeloma Mouse Model
Mari I Suominen, Jenni Mäki-Jouppila, Anna Huhtinen, et al.
Page
of 2